• About us
  • Membership
  • Contact us
  • Sat July 12, 2025

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

spinal muscular atrophy

Total:2

  • Oral medicine for SMA patients delivered to Iran 2022-08-09 18:47

    Oral medicine for SMA patients delivered to Iran

    TEHRAN – The first shipment of Evrysdi, an oral medication used to treat spinal muscular atrophy (SMA), has been imported to the country, Saeed Azamian, CEO of the SMA Association of Iran, said on Tuesday.

  • FDA imports medicine for SMA patients 2022-08-02 18:57

    FDA imports medicine for SMA patients

    TEHRAN – The first batch of SPINRAZA – a drug special for patients suffering from spinal muscular atrophy (SMA) - has arrived in the country, the Food and Drug Administration director announced on Tuesday.

All Pages

Latest

  • China champions cultural concord: Beijing hosts Global Civilizations Dialogue Ministerial Meeting

  • Milestone recognition marks Iran’s first Paleolithic World Heritage site

  • Is Geagea pushing his ministers to resign?

  • US move against UN Gaza investigator comes as a shock 

  • Chinese online literature offers global readers a window into modern China

  • Exploring cultural richness of ‘pearl of Silk Road’ Kashgar

  • What’s in Tehran art galleries

  • New mural of Ayatollah Khamenei unveiled, celebrating resistance, patriotism

  • IAF to show Chris Marker’s “Description of a Struggle”

  • Undermining the enemy's calculation

  • VP says Leader, public unity key to Iran’s resilience in 12-day war

  • Silence is complicity: Iran envoy to Denmark slams Israeli attacks on hospitals

  • Ayatollah Khamenei personally commanded war room

  • US-backed Israeli aggression a gross violation of intl. law: Iran envoy to UN

  • 15095

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio